China NMPA Drug Inspection - Huanggang Jingui Traditional Chinese Medicine Industry Development Co., Ltd. - Coptis chinensis slices
China NMPA drug inspection for Huanggang Jingui Traditional Chinese Medicine Industry Development Co., Ltd. published October 18, 2019. Drug: Coptis chinensis slices. The Shanghai Municipal Drug Administration (SMDA) issued its 2019 Issue 8 Drug Quality Sampling Inspection Announcement
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Huanggang Jingui Traditional Chinese Medicine Industry Development Co., Ltd. published October 18, 2019. Drug: Coptis chinensis slices. The Shanghai Municipal Drug Administration (SMDA) issued its 2019 Issue 8 Drug Quality Sampling Inspection Announcement
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox